JHP Pharmaceuticals, LLC acquired the rights to Dantrium® for the US and Canada, including supply rights in Australia, New Zealand, Israel and Chile while SpePharm Holding, BV acquired the rights in the rest of the world. JHP, headquartered in New Jersey is a specialty pharmaceutical company which manufactures and sells pharmaceutical products, primarily aseptic injectable products into the hospital segment, and provides contract manufacturing of sterile products for innovator pharmaceutical companies.


For more information about JHP please visit
www.jhppharma.com.